Ramot:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ramot - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10843
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ramot is a business engagement center of Tel Aviv University that offers technology transfer services. The center manages new technologies from university laboratories to the domestic and commercial markets. It also offers services which include research and development programs, securing appropriate financial support for research, patenting discoveries, and crafting licensing agreements with industry partners capable of propelling. Ramot also provides identifying improvements with market potential. The center offers its services to life sciences and biotechnology, mechanical engineering, agriculture, electronics and electro-optics, defence and security, environmental and cleantech, ICT and media, and medical devices and diagnostics sectors, among others. Ramot is headquartered in Tel Aviv, Israel.

Ramot – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ramot, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ramot, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ramot, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ramot, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ramot, Medical Devices Deals, 2012 to YTD 2018 9
Ramot, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ramot, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ramot at Tel Aviv University Enters into Research Agreement with Merck 11
Kalytera Therapeutics Enters into Research Agreement with Ramot at Tel Aviv University 12
Kalytera Therapeutics Enters into Research Agreement with Ramot at Tel Aviv University 13
Ramot at Tel Aviv University Enters into Research Agreement with Neurimmune 14
Kadimastem Enters into Research Agreement with Ramot at Tel Aviv University 15
Rosetta Genomics Enters Into Agreement With Ramot To Develop Nano-Carrier Delivery System To Treat Cancer 16
Licensing Agreements 17
BioLight Life Sciences Enters into Licensing Agreement with Fischer Pharma and Ramot 17
Coronis NeuroSciences Enters into Licensing Agreement with Ramot 18
Therapix Biosciences Enters into Licensing Agreement with Ramot at Tel Aviv University 19
Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 20
Aerie Pharma Enters into Licensing Agreement with Ramot at Tel Aviv University 21
Dexcel Pharma Enters into Licensing Agreement with Ramot at Tel Aviv University 22
Ramot – Key Competitors 23
Ramot – Key Employees 24
Ramot – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Ramot, Pharmaceuticals & Healthcare, Key Facts 2
Ramot, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ramot, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ramot, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ramot, Deals By Therapy Area, 2012 to YTD 2018 8
Ramot, Medical Devices Deals, 2012 to YTD 2018 9
Ramot, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ramot at Tel Aviv University Enters into Research Agreement with Merck 11
Kalytera Therapeutics Enters into Research Agreement with Ramot at Tel Aviv University 12
Kalytera Therapeutics Enters into Research Agreement with Ramot at Tel Aviv University 13
Ramot at Tel Aviv University Enters into Research Agreement with Neurimmune 14
Kadimastem Enters into Research Agreement with Ramot at Tel Aviv University 15
Rosetta Genomics Enters Into Agreement With Ramot To Develop Nano-Carrier Delivery System To Treat Cancer 16
BioLight Life Sciences Enters into Licensing Agreement with Fischer Pharma and Ramot 17
Coronis NeuroSciences Enters into Licensing Agreement with Ramot 18
Therapix Biosciences Enters into Licensing Agreement with Ramot at Tel Aviv University 19
Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 20
Aerie Pharma Enters into Licensing Agreement with Ramot at Tel Aviv University 21
Dexcel Pharma Enters into Licensing Agreement with Ramot at Tel Aviv University 22
Ramot, Key Competitors 23
Ramot, Key Employees 24

List of Figures
Ramot, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ramot, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ramot, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ramot, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ramot, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ramot, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ramot, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ramot, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ramot, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Ramot:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncology Venture ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB, is a developer of oncology products. The company offers products in the therapeutic areas of metastatic breast cancer, ovarian cancer, renal cancer, liver cancer, prostate cancer, multiple myeloma, and other …
  • Exeltis Pharmaceuticals Holding SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Exeltis Pharmaceuticals Holding SL (Exeltis), a subsidiary of Insud Pharma, is a developer, producer, and marketer of medicinal products and medical devices. The company provides products in the therapeutic areas including women’s health, dermatology, respiratory, central nervous system, inf …
  • Tiscali Group:企業の戦略・SWOT・財務分析
    Tiscali Group - Strategy, SWOT and Corporate Finance Report Summary Tiscali Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Solstad Farstad ASA (SOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Solstad Farstad ASA (Solstad), formerly Solstad Offshore ASA is an oil and gas company that provides vessel operation solutions. The company offers carbon footprint, climate neutral network, offshore shipping, green operations, and rainforest protection, documentation programs, and others. I …
  • ATCO Power Ltd:企業の戦略的SWOT分析
    ATCO Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Funtastic Ltd (FUN):企業の財務・戦略的SWOT分析
    Funtastic Ltd (FUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Helius Medical Technologies Inc (HSM):製品パイプライン分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that offers neurological wellness solutions. The company offers development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It offers development of technolog …
  • AngioDynamics Inc (ANGO):医療機器:M&Aディール及び事業提携情報
    Summary AngioDynamics Inc (AngioDynamics) is a provider of minimally invasive medical, surgical and diagnostic devices. Its product portfolio encompasses peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, prod …
  • Wynn Macau Ltd:戦略・SWOT・企業財務分析
    Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report Summary Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Wolters Kluwer nv:企業の戦略・SWOT・財務分析
    Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report Summary Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • DLF Ltd:企業の戦略・SWOT・財務分析
    DLF Ltd - Strategy, SWOT and Corporate Finance Report Summary DLF Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Guided Therapeutics Inc (GTHP)-医療機器分野:企業M&A・提携分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva advanced c …
  • University of Maryland Medical Center Corp:企業の戦略的SWOT分析
    University of Maryland Medical Center Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Phagelux Inc-製薬・医療分野:企業M&A・提携分析
    Summary Phagelux Inc (Phagelux) is an anti-infectives company that provides antibacterial products and solutions. The company uses phage lysis enzymes and biological agents for the treatment of antibiotic resistant bacteria and related diseases in human beings and crops. Its product portfolio includ …
  • DNAtrix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …
  • EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報
    Summary EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and med …
  • Neuwave Medical Inc-医療機器分野:企業M&A・提携分析
    Summary NeuWave Medical Inc (NeuWave), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. Its flagship product, Certus 140 microwave ablation (coagulation) system, is a minimally invasive soft tissue ablation s …
  • Astron Corp Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Intercede Group plc (IGP):企業の財務・戦略的SWOT分析
    Intercede Group plc (IGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Samsung Biologics Co Ltd (207940):製薬・医療:M&Aディール及び事業提携情報
    Summary Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The company’s business activities include process development, contract manufacturing, aseptic fill and finish and project management. Samsung Biologics cell culture development process include …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆